Clinical Trial Update: CoreHip - Post Market Clinical Follow-Up Study

View source ↗

Summary

The CoreHip post-market clinical follow-up study sponsored by Aesculap AG is active but not recruiting, evaluating hip-related outcomes in conditions including …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hip Fracture
• Osteoarthritis
• Osteonecrosis of the Femoral Head
• Rheumatoid Arthritis

Snippet

Sponsor: Aesculap AG | Conditions: Degenerative Osteoarthritis, Rheumatic Arthritis | Status: ACTIVE_NOT_RECRUITING